Ensysce Biosciences, Inc.
Developing safer opioids with abuse-deterrent and overdose protection technology for severe pain.
ENSC | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 7946 IVANHOE AVENUE, 92037 LA JOLLA
- Website:
- https://ensysce.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Ensysce Biosciences, Inc. is a clinical-stage biotechnology company dedicated to developing safer prescription drugs for severe pain to address the opioid epidemic. The company utilizes its proprietary technology platforms, Trypsin-Activated Abuse Protection (TAAP™) and Multi-Pill Abuse Resistance (MPAR®), to create novel opioids with built-in abuse deterrence and overdose protection. The TAAP™ platform creates prodrugs that are activated only in the gastrointestinal tract, minimizing abuse via non-oral routes. The MPAR® system is designed to prevent overdose by limiting drug activation when excessive doses are consumed. The company's lead product candidate, PF614, has received 'Fast Track' and 'Breakthrough Therapy' designations from the FDA.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Ensysce Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ensysce Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ensysce Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
